One-year net survival (NS, %) overall, age-standardised and age-specific, by stage at diagnosis and country for patients with non-small cell lung cancer diagnosed during 2004–2007
| Australia* | Canada† | Denmark | Norway | Sweden‡ | UK§ | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | NS (%) | 95% CI | |
| TNM stage | ||||||||||||
| All patients | ||||||||||||
| All ages | 41.8 | 40.7 to 42.8 | 35.4 | 34.6 to 36.2 | 46.1 | 44.7 to 47.5 | 28.8 | 28.3 to 29.4 | ||||
| Age-standardised | 41.7 | 40.9 to 42.5 | 34.1 | 33.5 to 34.7 | 45.5 | 44.5 to 46.6 | 29.6 | 29.1 to 30.0 | ||||
| 15–54 | 50.4 | 47.9 to 53.0 | 45.4 | 43.3 to 47.4 | 54.2 | 50.6 to 57.7 | 41.5 | 39.6 to 43.5 | ||||
| 55–74 | 44.2 | 42.9 to 45.5 | 39.3 | 38.4 to 40.3 | 48.0 | 46.4 to 49.7 | 32.5 | 31.7 to 33.2 | ||||
| 75–99 | 36.0 | 34.5 to 37.5 | 24.9 | 23.8 to 26.0 | 40.7 | 38.5 to 42.9 | 22.6 | 21.8 to 23.3 | ||||
| Stage I | ||||||||||||
| All ages | 86.2 | 84.6 to 87.8 | 75.0 | 73.1 to 76.9 | 88.8 | 86.7 to 90.9 | 71.1 | 69.4 to 72.9 | ||||
| Age-standardised | 86.3 | 85.3 to 87.3 | 73.3 | 71.9 to 74.6 | 88.4 | 87.0 to 89.8 | 72.5 | 71.4 to 73.6 | ||||
| 15–54 | 95.5 | 94.1 to 96.9 | 92.4 | 90.6 to 94.2 | 94.5 | 92.1 to 96.8 | 90.0 | 88.0 to 92.0 | ||||
| 55–74 | 89.5 | 88.0 to 91.0 | 79.7 | 77.8 to 81.6 | 89.9 | 87.9 to 91.8 | 77.5 | 75.6 to 79.3 | ||||
| 75–99 | 79.5 | 76.6 to 82.3 | 59.8 | 56.2 to 63.5 | 85.2 | 81.6 to 88.8 | 60.9 | 58.2 to 63.6 | ||||
| Stage II | ||||||||||||
| All ages | 79.0 | 75.2 to 82.7 | 60.8 | 57.1 to 64.5 | 70.3 | 63.1 to 77.6 | 58.6 | 55.7 to 61.5 | ||||
| Age-standardised | 78.5 | 76.3 to 80.7 | 59.1 | 56.8 to 61.5 | 70.7 | 66.8 to 74.7 | 59.8 | 57.9 to 61.7 | ||||
| 15–54 | 89.7 | 86.6 to 92.8 | 79.0 | 73.6 to 84.4 | 88.7 | 83.2 to 94.1 | 79.9 | 74.5 to 85.2 | ||||
| 55–74 | 82.4 | 79.0 to 85.9 | 64.9 | 61.1 to 68.8 | 75.5 | 69.0 to 82.1 | 65.3 | 62.1 to 68.5 | ||||
| 75–99 | 69.0 | 63.6 to 74.5 | 46.0 | 40.8 to 51.2 | 58.2 | 48.6 to 67.8 | 45.5 | 41.6 to 49.4 | ||||
| Stage III | ||||||||||||
| All ages | 43.2 | 41.3 to 45.2 | 45.0 | 43.3 to 46.8 | 47.1 | 44.5 to 49.8 | 34.4 | 33.1 to 35.8 | ||||
| Age-standardised | 44.0 | 42.5 to 45.4 | 42.8 | 41.5 to 44.1 | 46.4 | 44.5 to 48.4 | 35.3 | 34.3 to 36.3 | ||||
| 15–54 | 53.5 | 48.1 to 58.9 | 57.8 | 53.6 to 61.9 | 55.4 | 48.3 to 62.4 | 44.4 | 40.2 to 48.6 | ||||
| 55–74 | 49.3 | 46.7 to 51.8 | 49.4 | 47.4 to 51.5 | 52.5 | 49.4 to 55.7 | 39.6 | 37.9 to 41.4 | ||||
| 75–99 | 33.2 | 30.4 to 35.9 | 30.8 | 28.0 to 33.5 | 35.7 | 31.8 to 39.6 | 26.3 | 24.6 to 28.1 | ||||
| Stage IV | ||||||||||||
| All ages | 16.8 | 15.7 to 17.8 | 21.4 | 20.5 to 22.3 | 25.9 | 24.1 to 27.7 | 15.5 | 14.7 to 16.2 | ||||
| Age-standardised | 16.8 | 16.0 to 17.6 | 20.8 | 20.1 to 21.5 | 25.6 | 24.3 to 27.0 | 15.9 | 15.3 to 16.4 | ||||
| 15–54 | 24.0 | 21.0 to 27.1 | 27.4 | 24.9 to 29.8 | 31.1 | 26.3 to 35.9 | 24.5 | 22.0 to 27.1 | ||||
| 55–74 | 17.5 | 16.1 to 18.8 | 23.5 | 22.4 to 24.6 | 27.1 | 24.9 to 29.2 | 17.1 | 16.1 to 18.0 | ||||
| 75–99 | 13.2 | 11.7 to 14.6 | 14.4 | 13.2 to 15.7 | 21.7 | 19.0 to 24.5 | 10.9 | 9.9 to 11.8 | ||||
| Missing stage | ||||||||||||
| All ages | 42.2 | 38.4 to 46.0 | 19.2 | 17.3 to 21.0 | 34.4 | 29.0 to 39.9 | 20.6 | 19.7 to 21.5 | ||||
| Age-standardised | 38.7 | 35.4 to 42.0 | 19.6 | 18.1 to 21.1 | 34.7 | 30.4 to 39.1 | 20.6 | 19.9 to 21.2 | ||||
| 15–54 | 88.4 | 82.4 to 94.4 | 40.5 | 31.7 to 49.3 | 49.7 | 31.0 to 68.5 | 42.1 | 38.0 to 46.1 | ||||
| 55–74 | 40.8 | 34.4 to 47.2 | 21.3 | 18.4 to 24.1 | 40.2 | 31.5 to 48.9 | 23.7 | 22.4 to 25.0 | ||||
| 75–99 | 33.2 | 28.0 to 38.5 | 15.8 | 13.6 to 18.1 | 29.7 | 23.1 to 36.3 | 16.0 | 14.9 to 17.0 | ||||
| SEER Summary Stage 2000 | ||||||||||||
| All patients | ||||||||||||
| All ages | 41.8 | 40.9 to 42.7 | 41.8 | 40.8 to 42.8 | 35.4 | 34.6 to 36.2 | 38.4 | 37.4 to 39.5 | 46.0 | 44.6 to 47.5 | 30.4 | 28.8 to 31.9 |
| Age-standardised | 42.4 | 41.7 to 43.1 | 42.0 | 41.3 to 42.8 | 34.6 | 34.0 to 35.2 | 38.5 | 37.7 to 39.3 | 45.8 | 44.7 to 46.8 | 30.9 | 29.7 to 32.0 |
| 15–54 | 53.5 | 51.1 to 56.0 | 50.1 | 47.5 to 52.7 | 45.0 | 43.0 to 47.1 | 49.8 | 46.9 to 52.7 | 53.8 | 50.3 to 57.4 | 46.1 | 41.3 to 50.9 |
| 55–74 | 46.4 | 45.3 to 47.6 | 44.2 | 42.9 to 45.4 | 39.2 | 38.3 to 40.2 | 42.9 | 41.6 to 44.2 | 47.9 | 46.3 to 49.6 | 32.5 | 30.6 to 34.4 |
| 75–99 | 32.8 | 31.5 to 34.0 | 36.2 | 34.7 to 37.6 | 25.1 | 24.0 to 26.2 | 29.0 | 27.6 to 30.5 | 40.8 | 38.6 to 42.9 | 24.3 | 22.2 to 26.4 |
| Localised | ||||||||||||
| All ages | 63.2 | 61.5 to 64.9 | 85.8 | 84.2 to 87.5 | 73.9 | 71.9 to 75.8 | 74.9 | 72.6 to 77.1 | 88.3 | 86.2 to 90.5 | 67.5 | 62.9 to 72.1 |
| Age-standardised | 64.4 | 63.3 to 65.5 | 86.1 | 85.1 to 87.0 | 72.5 | 71.3 to 73.7 | 74.9 | 73.6 to 76.2 | 87.8 | 86.5 to 89.0 | 68.1 | 65.7 to 70.6 |
| 15–54 | 83.8 | 81.3 to 86.2 | 94.1 | 93.1 to 95.2 | 87.4 | 85.5 to 89.3 | 89.1 | 87.2 to 91.0 | 95.4 | 94.2 to 96.6 | 85.9 | 82.7 to 89.0 |
| 55–74 | 71.4 | 69.6 to 73.2 | 89.7 | 88.3 to 91.0 | 78.3 | 76.5 to 80.1 | 80.3 | 78.3 to 82.3 | 90.8 | 89.1 to 92.6 | 74.1 | 70.0 to 78.2 |
| 75–99 | 48.5 | 46.1 to 50.9 | 78.5 | 76.0 to 80.9 | 60.5 | 57.5 to 63.4 | 63.4 | 60.1 to 66.6 | 81.7 | 78.5 to 85.0 | 55.8 | 50.0 to 61.6 |
| Regional | ||||||||||||
| All ages | 52.8 | 50.7 to 54.9 | 53.6 | 51.5 to 55.7 | 51.2 | 49.4 to 53.0 | 47.4 | 45.4 to 49.4 | 54.2 | 51.3 to 57.1 | 46.5 | 42.4 to 50.7 |
| Age-standardised | 52.3 | 51.1 to 53.6 | 55.2 | 54.1 to 56.4 | 50.0 | 48.9 to 51.1 | 47.6 | 46.4 to 48.7 | 54.7 | 53.2 to 56.3 | 46.3 | 44.1 to 48.5 |
| 15–54 | 67.1 | 64.1 to 70.2 | 69.7 | 67.1 to 72.4 | 64.9 | 62.1 to 67.6 | 63.1 | 60.2 to 66.1 | 68.9 | 65.6 to 72.3 | 61.6 | 57.0 to 66.1 |
| 55–74 | 58.4 | 56.2 to 60.6 | 61.2 | 59.0 to 63.3 | 56.1 | 54.2 to 58.0 | 54.1 | 52.1 to 56.2 | 60.9 | 58.1 to 63.7 | 52.2 | 48.0 to 56.3 |
| 75–99 | 37.8 | 35.2 to 40.4 | 39.9 | 37.4 to 42.4 | 36.3 | 34.0 to 38.6 | 32.9 | 30.6 to 35.3 | 40.3 | 36.9 to 43.7 | 32.6 | 28.1 to 37.1 |
| Distant | ||||||||||||
| All ages | 17.6 | 16.5 to 18.6 | 18.5 | 17.4 to 19.6 | 22.9 | 22.0 to 23.8 | 18.3 | 17.1 to 19.5 | 27.3 | 25.6 to 28.9 | 18.6 | 16.4 to 20.8 |
| Age-standardised | 17.9 | 17.1 to 18.7 | 18.7 | 17.9 to 19.5 | 22.4 | 21.8 to 23.1 | 18.5 | 17.7 to 19.4 | 27.1 | 25.9 to 28.4 | 18.3 | 16.7 to 20.0 |
| 15–54 | 30.1 | 26.8 to 33.4 | 25.0 | 22.1 to 28.0 | 29.3 | 27.0 to 31.7 | 26.3 | 22.8 to 29.8 | 31.9 | 27.4 to 36.4 | 25.1 | 18.9 to 31.4 |
| 55–74 | 19.6 | 18.2 to 21.0 | 19.4 | 18.0 to 20.7 | 25.1 | 24.0 to 26.2 | 20.6 | 19.1 to 22.2 | 29.0 | 26.9 to 31.0 | 19.3 | 16.8 to 21.9 |
| 75–99 | 10.1 | 8.9 to 11.4 | 15.0 | 13.5 to 16.5 | 15.6 | 14.3 to 16.8 | 12.1 | 10.6 to 13.5 | 22.3 | 19.8 to 24.8 | 14.3 | 11.2 to 17.5 |
| Missing stage | ||||||||||||
| All ages | 45.8 | 44.0 to 47.7 | 42.3 | 38.6 to 45.9 | 19.3 | 17.4 to 21.2 | 42.2 | 38.9 to 45.4 | 35.0 | 29.5 to 40.5 | 23.2 | 21.0 to 25.4 |
| Age-standardised | 45.6 | 44.2 to 47.0 | 40.2 | 37.1 to 43.2 | 19.9 | 18.4 to 21.5 | 41.8 | 39.3 to 44.4 | 35.5 | 31.2 to 39.9 | 23.1 | 21.4 to 24.8 |
| 15–54 | 61.0 | 55.2 to 66.8 | 88.5 | 83.0 to 94.0 | 40.5 | 31.6 to 49.4 | 72.1 | 62.3 to 82.0 | 50.0 | 31.2 to 68.7 | 55.5 | 47.1 to 63.8 |
| 55–74 | 50.4 | 47.9 to 52.9 | 42.9 | 37.1 to 48.7 | 21.8 | 18.9 to 24.7 | 49.7 | 45.1 to 54.3 | 41.0 | 32.3 to 49.8 | 24.3 | 21.3 to 27.3 |
| 75–99 | 39.9 | 37.5 to 42.4 | 33.3 | 28.3 to 38.2 | 15.7 | 13.4 to 17.9 | 32.2 | 28.0 to 36.4 | 30.1 | 23.4 to 36.8 | 18.6 | 15.9 to 21.3 |
*Australia: New South Wales.
†Canada: Alberta and Manitoba.
‡Sweden: Uppsala-Örebro and Stockholm-Gotland health regions.
§UK (TNM analysis): West Midlands Cancer Intelligence Unit Eastern Cancer Registration and Information Centre in England and Northern Ireland; UK (SEER analysis): Northern Ireland.